This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Sep;11(9):747; author reply 747-8.

doi: 10.1016/S1474-4422(12)70181-3.

Reporting of subgroup analyses from clinical trials

Maria Pia Sormani, Paolo Bruzzi

PMID: 22898729
DOI: 10.1016/S1474-4422(12)70181-3

Comment

Reporting of subgroup analyses from clinical trials

Maria Pia Sormani et al. Lancet Neurol. 2012 Sep.

. 2012 Sep;11(9):747; author reply 747-8.

doi: 10.1016/S1474-4422(12)70181-3.

Authors

Maria Pia Sormani, Paolo Bruzzi

PMID: 22898729
DOI: 10.1016/S1474-4422(12)70181-3

No abstract available

PubMed Disclaimer

Comment on

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
Devonshire V, Havrdova E, Radue EW, O'Connor P, Zhang-Auberson L, Agoropoulou C, Häring DA, Francis G, Kappos L; FREEDOMS study group. Devonshire V, et al. Lancet Neurol. 2012 May;11(5):420-8. doi: 10.1016/S1474-4422(12)70056-X. Epub 2012 Apr 10. Lancet Neurol. 2012. PMID: 22494956 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey